An increase of CD3+/CD56− or CD3−/CD56+ cells by peripheral-blood flow cytometry and/or an inverted CD4+/CD8+ cell ratio (<1·0) suggests the existence of LGL leukaemia (Gonzales-Chambers et al, 1992). The gene discussed is NCAM1; the disease is T-cell large granular lymphocyte leukemia.